Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies

Paediatric Respiratory Reviews

Volumn 26, Issue , 2018, Pages 41-48

  Tramper Stranders, Gerdien A ^a,b  

^a Franciscus Gasthuis & Vlietland ^*  (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Antimicrobial treatment; Children; Epidemiology; Etiology; Pneumonia

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN; CORTICOSTEROID; COTRIMOXAZOLE; MACROLIDE; OSELTAMIVIR; OXACILLIN; PENICILLIN DERIVATIVE; PLACEBO; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; BLOOD CULTURE; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG DOSAGE FORM COMPARISON; EMPYEMA; FEVER; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LOW INCOME COUNTRY; LUNG ASPIRATION; LUNG BIOPSY; MIDDLE INCOME COUNTRY; PLEURA EMPYEMA; PRIORITY JOURNAL; REVIEW; SPUTUM ANALYSIS; TREATMENT DURATION; VIRUS PNEUMONIA; WATCHFUL WAITING; WHEEZING; CHILD; COMMUNITY ACQUIRED INFECTION; DISEASE MANAGEMENT; MICROBIOLOGY; PNEUMONIA;

ANTI-BACTERIAL AGENTS; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DISEASE MANAGEMENT; HUMANS; PNEUMONIA;

EID: 85028063767     PISSN: 15260542     EISSN: 15260550     Source Type: Journal    
DOI: 10.1016/j.prrv.2017.06.013     Document Type: Review

References (80)

1. Walker, C.L.F., Rudan, I., Liu, L., Nair, H., Theodoratou, E., Bhutta, Z., et al. Global burden of childhood pneumonia and diarrhoea. Lancet 381 (2013), 1405–1416.
2. Oliwa, J., Karumbi, J., Marais, B., Madhi, S., Graham, S., Tuberculosis as a cause or comorbidity of childhood pneumonia in tuberculosis-endemic areas: a systematic review. Lancet Respir Med 3 (2015), 235–243.
3. Shann, F., Etiology of severe pneumonia in children in developing countries. Pediatr Infect Dis 5 (1986), 247–252.
4. Rudan, I., Boschi Pinto, C., Biloglav, Z., Mulholland, K., Campbell, H., Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86 (2008), 408–416.
5. Liu, L., Johnson, H., Cousens, S., Perin, J., Scott, S., Lawn, J., et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379 (2012), 2151–2161.
6. Rudan, I., O'Brien, K., Nair, H., Liu, L., Theodoratou, E., Qazi, S., et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health, 3, 2013, 010401.
7. Greenberg, D., Givon Lavi, N., Ben Shimol, S., Ziv, J., Dagan, R., Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. Vaccine 33 (2015), 4623–4629.
8. Theodoratou, E., Johnson, S., Jhass, A., Madhi, S., Clark, A., Boschi Pinto, C., et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol 39:Suppl 1 (2010), i172–i185.
9. Flasche, S., Takahashi, K., Vu, D., Suzuki, M., Nguyen, T., Le, H., et al. Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam. Vaccine 32 (2014), 6963–6970.
10. Turner, G.D.H., Bunthi, C., Wonodi, C., Morpeth, S., Molyneux, C., Zaki, S., et al. The role of postmortem studies in pneumonia etiology research. Clin Infect Dis 54:Suppl 2 (2012), S165–S171.
11. McCulloh, R., Koster, M., Yin, D., Milner, T., Ralston, S., Hill, V., et al. Evaluating the use of blood cultures in the management of children hospitalized for community-acquired pneumonia. PLoS ONE, 10, 2015, e0117462.
12. Andrews, A., Simpson, A., Heine, D., Teufel, R., A cost-effectiveness analysis of obtaining blood cultures in children hospitalized for community-acquired pneumonia. J Pediatr, 2015.
13. Bustamante Calvillo, M.E., Velázquez, F.R., Cabrera Munõz, L., Torres, J., Gómez Delgado, A., Moreno, J.A., et al. Molecular detection of respiratory syncytial virus in postmortem lung tissue samples from Mexican children deceased with pneumonia. Pediatr Infect Dis J 20 (2001), 495–501.
14. Hu, H., He, L., Dmitriev, A., Hu, Y., Deng, J., Zhang, W., et al. The role of Haemophilus influenzae type b in fatal community-acquired pneumonia in Chinese children. Pediatr Infect Dis J 27 (2008), 942–944.
15. Levine, O., O'Brien, K., Deloria Knoll, M., Murdoch, D., Feikin, D., DeLuca, A., et al. The Pneumonia Etiology Research for Child Health Project: a 21st century childhood pneumonia etiology study. Clin Infect Dis 54:Suppl 2 (2012), S93–S101.
16. Pernica, J., Moldovan, I., Chan, F., Slinger, R., Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children. Can J Infect Dis Med Microbiol 25 (2014), 151–154.
17. Sakran, W., Ababseh, Z.E.D., Miron, D., Koren, A., Thoracic empyema in children: clinical presentation, microbiology analysis and therapeutic options. J Infect Chemother 20 (2014), 262–265.
18. De Schutter, I., Vergison, A., Tuerlinckx, D., Raes, M., Smet, J., Smeesters, P., et al. Pneumococcal aetiology and serotype distribution in paediatric community-acquired pneumonia. PLoS ONE, 9, 2014, e89013.
19. Lochindarat, S., Teeratakulpisarn, J., Warachit, B., Chanta, C., Thapa, K., Gilbert, G., et al. Bacterial etiology of empyema thoracis and parapneumonic pleural effusion in Thai children aged less than 16 years. Southeast Asian J Trop Med Public Health 45 (2014), 442–454.
20. Zampoli, M., Kappos, A., Wolter, N., von Gottberg, A., Verwey, C., Mamathuba, R., et al. Etiology and incidence of pleural empyema in South African children. Pediatr Infect Dis J 34 (2015), 1305–1310.
21. Hammitt, L., Kazungu, S., Morpeth, S., Gibson, D., Mvera, B., Brent, A., et al. A preliminary study of pneumonia etiology among hospitalized children in Kenya. Clin Infect Dis 54:Suppl 2 (2012), S190–S199.
22. Mermond, S., Zurawski, V., D'Ortenzio, E., Driscoll, A., DeLuca, A., Deloria Knoll, M., et al. Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health Project. Clin Infect Dis 54:Suppl 2 (2012), S180–S189.
23. Honkinen, M., Lahti, E., Österback, R., Ruuskanen, O., Waris, M., Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect 18 (2012), 300–307.
24. Elemraid, M., Sails, A., Eltringham, G.J.A., Perry, J., Rushton, S., Spencer, D., et al. Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine. Eur Respir J 42 (2013), 1595–1603.
25. Pavia, A., Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 52:Suppl 4 (2011), S284–S289.
26. Jain, S., Williams, D., Arnold, S., Ampofo, K., Bramley, A., Reed, C., et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372 (2015), 835–845.
27. Liu, J., Ai, H., Xiong, Y., Li, F., Wen, Z., Liu, W., et al. Prevalence and correlation of infectious agents in hospitalized children with acute respiratory tract infections in Central China. PLoS ONE, 10, 2015, e0119170.
28. Lochindarat, S., Suwanjutha, S., Prapphal, N., Chantarojanasiri, T., Bunnag, T., Deerojanawong, J., et al. Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand. Int J Tuberc Lung Dis 11 (2007), 814–819.
29. Finelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D., Kamimoto, L., et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122 (2008), 805–811.
30. Straus, W.L., Qazi, S.A., Kundi, Z., Nomani, N.K., Schwartz, B., Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Co-trimoxazole Study Group. Lancet 352 (1998), 270–274.
31. Lodha, R., Kabra, S., Pandey, R., Antibiotics for community-acquired pneumonia in children. Cochrane Database Syst Rev, 6, 2013, CD004874.
32. Catchup Study Group, Clinical efficacy of co-trimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan. Arch Dis Child 86 (2002), 113–118.
33. Das, R., Singh, M., Treatment of severe community-acquired pneumonia with oral amoxicillin in under-five children in developing country: a systematic review. PLoS ONE, 8, 2013, e66232.
34. Bari, A., Sadruddin, S., Khan, A., Khan, Iu.H., Lehri, I., Macleod, W., et al. Community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Haripur district, Pakistan: a cluster randomised trial. Lancet 378 (2011), 1796–1803.
35. Soofi, S., Ahmed, S., Fox, M., MacLeod, W., Thea, D., Qazi, S., et al. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. Lancet 379 (2012), 729–737.
36. Campbell, H., Byass, P., Forgie, I.M., O'Neill, K.P., Lloyd Evans, N., Greenwood, B.M., Trial of co-trimoxazole versus procaine penicillin with ampicillin in treatment of community-acquired pneumonia in young Gambian children. Lancet 2 (1988), 1182–1184.
37. Hazir, T., Nisar, Y., Abbasi, S., Ashraf, Y., Khurshid, J., Tariq, P., et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2–59 months: a multicenter, double-blind, randomized, placebo-controlled trial in Pakistan. Clin Infect Dis 52 (2011), 293–300.
38. Awasthi, S., Agarwal, G., Kabra, S., Singhi, S., Kulkarni, M., More, V., et al. Does 3-day course of oral amoxycillin benefit children of non-severe pneumonia with wheeze: a multicentric randomised controlled trial. PLoS ONE, 3, 2008, e1991.
39. Addo Yobo, E., Chisaka, N., Hassan, M., Hibberd, P., Lozano, J., Jeena, P., et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet 364 (2004), 1141–1148.
40. Hazir, T., Fox, L., Nisar, Y., Fox, M., Ashraf, Y., MacLeod, W., et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Lancet 371 (2008), 49–56.
41. Aurangzeb, B., Hameed, A., Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children. J Coll Physicians Surg Pak 13 (2003), 704–707.
42. Asghar, R., Banajeh, S., Egas, J., Hibberd, P., Iqbal, I., Katep Bwalya, M., et al. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2–59 months in low resource settings: multicentre randomised controlled trial (SPEAR study). BMJ 336 (2008), 80–84.
43. Duke, T., Poka, H., Dale, F., Michael, A., Mgone, J., Wal, T., Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet 359 (2002), 474–480.
44. Jibril, H.B., Ifere, O.A., Odumah, D.U., An open, comparative evaluation of amoxycillin and amoxycillin plus clavulanic acid (‘Augmentin’) in the treatment of bacterial pneumonia in children. Curr Med Res Opin 11 (1989), 585–592.
45. Tsarouhas, N., Shaw, K.N., Hodinka, R.L., Bell, L.M., Effectiveness of intramuscular penicillin versus oral amoxicillin in the early treatment of outpatient pediatric pneumonia. Pediatr Emerg Care 14 (1998), 338–341.
46. Ambroggio, L., Test, M., Metlay, J., Graf, T., Ann Blosky, M., Macaluso, M., et al. Comparative effectiveness of beta-lactam versus macrolide monotherapy in children with pneumonia diagnosed in the outpatient setting. Pediatr Infect Dis J 34 (2015), 839–842.
47. Ambroggio, L., Test, M., Metlay, J., Graf, T., Blosky, M., Macaluso, M., et al. Beta-lactam versus beta- lactam/macrolide therapy in pediatric outpatient pneumonia. Pediatr Pulmonol, 2015.
48. Wubbel, L., Muniz, L., Ahmed, A., Trujillo, M., Carubelli, C., McCoig, C., et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 18 (1999), 98–104.
49. Kogan, R., Martínez, M.A., Rubilar, L., Payá E., Quevedo, I., Puppo, H., et al. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children. Pediatr Pulmonol 35 (2003), 91–98.
50. Leyenaar, J., Shieh, M., Lagu, T., Pekow, P., Lindenauer, P., Comparative effectiveness of ceftriaxone in combination with a macrolide compared with ceftriaxone alone for pediatric patients hospitalized with community-acquired pneumonia. Pediatr Infect Dis J 33 (2014), 387–392.
51. Bradley, J., Arguedas, A., Blumer, J., Sáez Llorens, X., Melkote, R., Noel, G., Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. Pediatr Infect Dis J 26 (2007), 868–878.
52. Dinur Schejter, Y., Cohen Cymberknoh, M., Tenenbaum, A., Brooks, R., Averbuch, D., Kharasch, S., et al. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime. Pediatr Pulmonol 48 (2013), 52–58.
53. Queen, M., Myers, A., Hall, M., Shah, S., Williams, D., Auger, K., et al. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia. Pediatrics 133 (2014), e23–e29.
54. Williams, D., Hall, M., Shah, S., Parikh, K., Tyler, A., Neuman, M., et al. Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia. Pediatrics 132 (2013), e1141–e1148.
55. Amarilyo, G., Glatstein, M., Alper, A., Scolnik, D., Lavie, M., Schneebaum, N., et al. IV Penicillin G is as effective as IV cefuroxime in treating community-acquired pneumonia in children. Am J Ther 21 (2014), 81–84.
56. Atkinson, M., Lakhanpaul, M., Smyth, A., Vyas, H., Weston, V., Sithole, J., et al. Comparison of oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children (PIVOT trial): a multicentre pragmatic randomised controlled equivalence trial. Thorax 62 (2007), 1102–1106.
57. Lorgelly, P.K., Atkinson, M., Lakhanpaul, M., Smyth, A.R., Vyas, H., Weston, V., et al. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis. Eur Respir J 35 (2010), 858–864.
58. Ribeiro, C., Ferrari, G., Fioretto, J., Antibiotic treatment schemes for very severe community-acquired pneumonia in children: a randomized clinical study. Rev Panam Salud Publica 29 (2011), 444–450.
59. Lassi, Z., Imdad, A., Bhutta, Z., Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. Cochrane Database Syst Rev, 6, 2015, CD008032.
60. Greenberg, D., Givon Lavi, N., Sadaka, Y., Ben Shimol, S., Bar Ziv, J., Dagan, R., Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial. Pediatr Infect Dis J 33 (2014), 136–142.
61. Haider, B., Saeed, M., Bhutta, Z., Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev, 2008.
62. Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group, Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 360 (2002), 835–841.
63. Vilas Boas, A., Fontoura, M., Xavier Souza, G., Araújo Neto, C., Andrade, S., Brim, R., et al. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial. J Antimicrob Chemother 69 (2014), 1954–1959.
64. Fonseca, W., Hoppu, K., Rey, L., Amaral, J., Qazi, S., Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia. Antimicrob Agents Chemother 47 (2003), 997–1001.
65. Rasmussen, Z., Bari, A., Qazi, S., Rehman, G., Azam, I., Khan, S., et al. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. Bull World Health Organ 83 (2005), 10–19.
66. Ambroggio, L., Test, M., Metlay, J., Graf, T., Blosky, M., Macaluso, M., et al. Adjunct systemic corticosteroid therapy in children with community-acquired pneumonia in the outpatient setting. J Pediatric Infect Dis Soc 4 (2015), 21–27.
67. Weiss, A., Hall, M., Lee, G., Kronman, M., Sheffler Collins, S., Shah, S., Adjunct corticosteroids in children hospitalized with community-acquired pneumonia. Pediatrics 127 (2011), e255–e263.
68. Nagy, B., Gaspar, I., Papp, A., Bene, Z., Voko, Z., Balla, G., Efficacy of methylprednisolone in children with severe community acquired pneumonia. Pediatr Pulmonol 48 (2013), 168–175.
69. Lavi, E., Shoseyov, D., Simanovsky, N., Brooks, R., Systemic steroid treatment for severe expanding pneumococcal pneumonia. Case Rep Pediatr, 2015, 2015, 186302.
70. Bueno, M., Calvo, C., Méndez Echevarría, A., de José M., Santos, M., Carrasco, J., et al. Oseltamivir treatment for influenza in hospitalized children without underlying diseases. Pediatr Infect Dis J 32 (2013), 1066–1069.
71. Jefferson, T., Jones, M., Doshi, P., Spencer, E., Onakpoya, I., Heneghan, C., Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ, 348, 2014, g2545.
72. Breuer, O., Blich, O., Cohen Cymberknoh, M., Averbuch, D., Kharasch, S., Shoseyov, D., et al. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy. Pediatr Pulmonol 50 (2015), 495–502.
73. Esposito, S., Cohen, R., Domingo, J., Pecurariu, O., Greenberg, D., Heininger, U., et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat?. Pediatr Infect Dis J 31 (2012), e78–e85.
74. Stockmann, C., Ampofo, K., Pavia, A., Byington, C., Sheng, X., Greene, T., et al. Comparative effectiveness of oral versus outpatient parenteral antibiotic therapy for empyema. Hosp Pediatr, 2015.
75. Shah, S.S., Srivastava, R., Wu, S., Colvin, J.D., Williams, D.J., Rangel, S.J., et al. Intravenous versus oral antibiotics for postdischarge treatment of complicated pneumonia. Pediatrics, 138, 2016, e20161692 Epub 2016 Nov 17.
76. Proesmans, M., De Boeck, K., Clinical practice: treatment of childhood empyema. Eur J Pediatr 168 (2009), 639–645.
77. Walker, W., Wheeler, R., Legg, J., Update on the causes, investigation and management of empyema in childhood. Arch Dis Child 96 (2011), 482–488.
78. Hibberd, P., Patel, A., Challenges in the design of antibiotic equivalency studies: the multicenter equivalency study of oral amoxicillin versus injectable penicillin in children aged 3–59 months with severe pneumonia. Clin Infect Dis 39 (2004), 526–531.
79. Cardoso, M., Nascimento Carvalho, C., Ferrero, F., Alves, F., Cousens, S., Adding fever to WHO criteria for diagnosing pneumonia enhances the ability to identify pneumonia cases among wheezing children. Arch Dis Child 96 (2011), 58–61.
80. Ferrero, F., Adrián Torres, F., Domínguez, P., Ossorio, M., Efficacy and safety of a decision rule for using antibiotics in children with pneumonia and vaccinated against pneumococcus. A randomized controlled trial. Arch Argent Pediatr 113 (2015), 397–403.